Recent executive changes in the industry include C-suite changes at ADC Therapeutics and ImmunoGen. Meanwhile, new directors were appointed at Aerie Pharmaceuticals and Adagene.

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Recent executive changes in the industry include C-suite changes at Sirnaomics and Horizon Therapeutics. Meanwhile, new directors were appointed at SIGA Technologies and Forte Biosciences.

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Recent executive moves in the industry include C-suite changes at Lipocine and Actinium Pharmaceuticals. Meanwhile, new directors were appointed at Immune-Onc Therapeutics and Blue Water Vaccines.